Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma

Background The inhibition of programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) signaling pathway has been shown to be an effective targeted therapy in fighting both solid organ cancers and hematological malignancies. PD-L1 expression also serves as a prognostic marker in various...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jian, Wang, Renching, Hasan, Syed, Tao, Luwei, Wazir, Mohammed, Jain, Akriti G, Zhu, Xiang, Perkins, Sherrie, Mohamed, Salama, Chang, Chung-Che, Mori, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559697/
https://www.ncbi.nlm.nih.gov/pubmed/31245191
http://dx.doi.org/10.7759/cureus.4401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559697/
https://www.ncbi.nlm.nih.gov/pubmed/31245191
http://dx.doi.org/10.7759/cureus.4401

Ejemplares similares